B of A Securities Maintains Neutral on Roivant Sciences, Raises Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Chi Fong has maintained a Neutral rating on Roivant Sciences (NASDAQ:ROIV) and increased the price target from $11 to $12.

January 02, 2024 | 3:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Roivant Sciences' price target has been raised from $11 to $12 by B of A Securities, while maintaining a Neutral rating.
The increase in price target by B of A Securities suggests a positive outlook on the value of Roivant Sciences, which could lead to increased investor confidence and a potential short-term rise in the stock price. However, the Neutral rating indicates that the analyst does not see significant momentum beyond the revised target, tempering the impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100